References
- Morelllon P, Que Y-A, Glauser MP. Staphylococcus aureus. In: Mandell GL, Bennett JR, Dolin R, editors. Principles and practice of infectious diseases. 6th ed. Philadelphia: Elsevier, 2005: 2321-51.
- Rennie RP, Jones RN, Mutnick AH. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2003; 45: 287–93.
- Hoban DJ, Biedenbach DJ, Mutnick AH, Jones RN. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalised patients in North America: results of the SENTRY antimicrobial surveillance study. Diagn Microbiol Infect Dis 2003; 45: 279–85.
- Deshpande LM, Fritsche TR, Jones RN. Molecular epi-demiology of selected multidrug-resistant bacteria: a global report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2004; 49: 231–6.
- Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39: 971–9.
- Charlebois ED, Perdreau-Remington F, Kreiswirth B, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2004; 39: 47–54.
- Gosbell IB, Mercer JL, Neville SA, Chant KG, Munro R. Community-acquired, non-multiresistant oxacillin-resistant Staphylococcus aureus (NORSA) in south western Sydney. Pathology 2001; 33 (2): 206–10.
- Mutnick AH, Enne V, Jones RN. Linezolid resistance since 2001: SENTRY antimicrobial surveillance program. Ann Pharmacother 2003; 37: 909–11.
- National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; Fourteenth informational supplement. NCCLS Document M100-513. 2004; 24 (1).
- Comite De LAntibiogramme De La Societe Francaise De Microbiologie. Report 2000-2001. Available at url: http:www.sfm.asso.fr/
- Finlay JE, Miller LA, Poupard JA. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agent Chemother 1997; 41: 1137–1139.
- Metallidis S., Chatzidimitriou M., Nikolaidis P. Comparative in vitro activity of linezolid and five other antimi-crobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium. J Chemother 2003; 15: 442-8.
- Fluit AC, Wielders CL, Verhoef J, Schmitz F-J. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolated from 25 university hospitals participating in the European SENTRY study. J Clin Microbiol 2001; 39: 3727-32.
- Tiemersma EW, Bronzwaer SL, Lyytikainen O, et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627–34.
- SaMra Z, Gadba R, Ofir O. Antibiotic susceptibility and phage typing of methicillin-resistant and sensitive Staphylococcus aureus clinical isolates at the period during 1991-1997. Eur J Clin Microbiol Infect Dis 2001; 20: 427–7/
- O'Neill AJ, Cove JH, Chopra I. Mutation frequencies for resistance to fusidic acid and rifampicin in Staphylococcus aureus. J Antimicrob Chemother 2001; 47: 647–50.
- Schmitz F-J, Fluit AC, Hafner D, et al. Development of resistance to ciprofloxacin, rifampin, and mupirocin in methi-cillin-susceptible and -resistant Staphylococcus aureus isolates. Antimicrob Agent Chemother 2000; 44: 3229–31.
- Kochman M, Fordymacki P, Lawrynowicz-Pacior M, et al. Susceptibility to selected chemotherapeutics Staphylococcus aureus strains resistant to methicillin isolated from clinical materials in the years 1991-1992 and 1997. Med Dosw Microbiol 1999; 51 (3-4):187-98.
- Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy. Int J Antimicrob Agents 2004; 23: 577–81.
- Nishijima S, Kurokawa I. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections. Int J Antimicrob Agents 2002; 19: 241–3.
- Hamilton-Miller JMT, Shah S. Patterns of phenotypic resistance to the macrolides-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J Antimicrob Chemother 2000; 46: 941–949.